Implementing FAIR principles is critical for reusing legacy and newly generated data for tackling high-value healthcare challenges. The prominent panelists in our most recent panel discussion, "Making the Case for F.A.I.R in Biopharma R&D," address FAIR concepts that can advance your data strategy.

Key Questions Answered:

• How can you convince your leadership to invest more in FAIR, and how can you address concerns about the expected returns?
• Are there established benchmarks or assessments that can be used to evaluate a company's progress along their FAIR data journey?
• What tangible or intangible returns have been observed by the panel that can be attributed to the implementation of FAIR principles?